| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 278.6K | $39.70M | - | |
| Other | 232.5K | $33.13M | - | |
| COO | 192.5K | $27.43M | - | |
| CFO | 108.1K | $15.40M | - | |
| ? | 96.6K | $13.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Horn Margaret A48 | Chief Operating Officer | Sale+OE | 75,000 | $100.56 | $7,542,022.51 | -14.4% | -6.3% | - | |
| Jan 7, 2026 | Anders Jack48 | Chief Financial Officer | Sale+OE | 10,000 | $98.00 | $980,000.00 | -8.5% | -6.3% | - | |
| Dec 16, 2025 | Cislini Jeff | General Counsel | Sell | 2,688 | $76.82 | $206,483.83 | -5.3% | +27.6% | - | |
| Dec 16, 2025 | Goldsmith Mark A53 | See Remarks | Sell | 15,394 | $76.82 | $1,182,525.52 | -6.2% | +27.6% | - | |
| Dec 16, 2025 | Kelsey Stephen Michael46 | See Remarks | Sell | 5,447 | $76.82 | $418,423.29 | -1.9% | +27.6% | - | |
| Dec 16, 2025 | Horn Margaret A48 | Chief Operating Officer | Sell | 4,847 | $76.82 | $372,333.45 | -3.3% | +27.6% | - | |
| Dec 16, 2025 | Anders Jack48 | Chief Financial Officer | Sell | 3,104 | $77.09 | $239,288.60 | -2.8% | +27.6% | - | |
| Nov 25, 2025 | Goldsmith Mark A53 | See Remarks | Sale+OE | 66,000 | $75.08 | $4,954,962.00 | -14.7% | +35.8% | - | |
| Nov 25, 2025 | Anders Jack48 | Chief Financial Officer | Sale+OE | 5,418 | $74.00 | $400,932.00 | -4.7% | +35.8% | - | |
| Nov 18, 2025 | Goldsmith Mark A53 | See Remarks | Sale+OE | 20,000 | $70.38 | $1,407,586.00 | -7.5% | +42.5% | - |